Physician

Ivan Pena Sing, M.D.

According to 2025 Medicare claims, Ivan Sing, M.D. (NPI: 1225021611) practices cardiology in the Elizabethtown, KY market, with the plurality of this provider's patient population coming from Hardin, KY. This provider's primary affiliated billing organization is BAPTIST HEALTH MEDICAL GROUP INC (NPI: 1093338527; TIN: 205497203) and primary practice location at 42701-2503. Sing is affiliated with the Baptist Health Care Partners, LLC (ACO ID: A2975), participating under the MSSP model.

Sing's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,041 traditional Medicare patients, billed 2,361 HCPCS/CPT codes, and received $102,449 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 898 prescription claims across 222 beneficiaries totaling $160,719 in drug costs, led by Jardiance (Empagliflozin). 2019 DME data shows 12 claims. Open Payments data shows 18 records totaling $883. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $453,448 and ending at $102,449. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $309,363 and ending at $160,719. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,023	6,550	$453,448
2016	1,536	4,003	$346,235
2017	740	3,392	$350,817
2018	1,290	4,729	$416,782
2019	832	2,996	$250,508
2020	468	1,159	$128,743
2021	2,315	3,822	$226,114
2022	4,939	8,887	$431,400
2023	3,068	5,497	$350,493
2024	1,041	2,361	$102,449

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	796	3,039	$309,363
2016	676	2,695	$304,140
2017	220	818	$66,798
2018	172	1,086	$98,881
2019	190	1,199	$143,716
2020	142	524	$64,822
2021	155	767	$105,298
2022	228	1,173	$178,396
2023	223	952	$174,874
2024	222	898	$160,719

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	12	$25,005
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	118	118	$115
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	81	207	$58
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	268	272	$50
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	111	144	$12
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	658	865	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	71	3,330	$63,114
Eliquis	Apixaban	51	2,212	$42,441
Brilinta	Ticagrelor	51	1,878	$27,135
Rosuvastatin Calcium	Rosuvastatin Calcium	76	3,305	$1,009
Metoprolol Succinate	Metoprolol Succinate	86	5,310	$707

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	18	$883	Teleflex LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ivan Pena Sing, M.D.?

Tedicare shows public-source Medicare data for Ivan Pena Sing, M.D. (NPI 1225021611), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ivan Pena Sing, M.D. have ACO affiliation data?

Ivan Pena Sing, M.D. is shown with ACO affiliation data for Baptist Health Care Partners, LLC (MSSP, ACO ID A2975).

What billing organization is linked to Ivan Pena Sing, M.D.?

Ivan Pena Sing, M.D. is linked to BAPTIST HEALTH MEDICAL GROUP INC (billing NPI 1093338527) in the available physician profile data.

Does Ivan Pena Sing, M.D. have Open Payments data?

Ivan Pena Sing, M.D. has 18 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.